Medical Policy and Coding Updates - August 2021
Summary
This Premera medical policy and coding update lists changes from August 2021. Effective August 1, 2021, a prescription digital therapeutics policy was added, with some FDA-approved products considered investigational, and continuous glucose monitoring supplies gained quantity limits. Coding changes effective August 1 and August 6, 2021 added medical necessity or prior authorization review to codes including J2353, J2354, J1930 and T1505, and a site of service review was added for J1429. The update also lists an allograft injection for degenerative disc disease as investigational, effective November 5, 2021.
Get alerts when payers change rules like this one
We check Premera Blue Cross and other payers every day and email you when a change matches your specialty and state.